Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
media
posted on 2021-05-19, 16:30 authored by Adis journals on behalf of, Márcia Waddington-Cruz, Jonas Wixner, Leslie Amass, Jan Kiszko, Doug Chapman, Yukio Ando on behalf of the THAOS investigators<div><b>Article full text</b></div><div><br></div><div>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). </div><div>© The authors, CC-BY-NC 2021. </div>
